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Abstract Oral and oropharyngeal cancers are characterized by
relatively low 5- year survival rates due to many factors, includ-
ing local recurrence. The identification of new molecular
markers may serve for the estimation of prognosis and thus
augment treatment decisions and affect therapy outcome. The
aim of this study was to describe the morphological character-
istics and the DNA methylation status of the CDKN2A,CDH1,
ATM, FHIT and RAR- genes in the central and peripheral part
of the tumor and the surgical margin and evaluate their prog-
nostic significance. 53 patients with oral and oropharyngeal
cancer were enrolled to the prospective study, and had been
primarily treated surgically. Correlations between morphologi-
cal data, hypermethylation status and clinicopathological data,
as well as prognosis, were assessed. Nuclei polymorphism
highly correlated with T stage (p<0.0001), N stage (p<0.046),
and metastases to the lymph nodes pN (p<0.004 ). Also, the
number of cells in irregular mitosis correlated with T stage
(p<0.004), and highly with pN (p<0.009). The significance of
CDKN2A hypermethylation as a good prognostic factor was
also established in the Kaplan-Meir test. The ultrastructural
analysis showed that none of the examined tumors had
homogenous texture and that resection margin specimens clean
in HE stained tissue samples frequently contained single tumor
cells or few cells in groups surrounded by connective tissue.
This indicates the superiority of electron microscopy over stan-
dard histopathological analysis. Thus, a combination of such
morphological examination with epigenetic parameters de-
scribed herein could result in the discovery of promising new
prognostic markers of the disease.
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Introduction
Oral cancer is a serious and growing medical problem. It is the
sixth most common cancer in the world and occurs in people
aged 50 and over [1, 2]. However, about 6 % of patients
suffering from this type of disease are under 45 years old, or
even under 40 in countries with a high incidence [3–6]. The
clinical data regarding the course of the disease are not clear-
cut [7]. The risk factors are well known (tobacco smoking,
alcohol abusing), but there are currently many reports regard-
ing non-smoking and non-drinking populations with HPV
infection [8–11]. Treatment failure is still high; thus, the
search for prognostic markers which could be useful in early
detection of recurrence is ongoing.
Amongmany prognostic factors, the assessment of surgical
margin seems to be crucial. Routine histopathological exam-
ination using hematoxylin–eosin staining of paraffin-
embedded tissue samples is a golden standard in evaluation
of the resection field by pathologists. However, this technique
does not allow to describe the ultrastructure of the tumor and
surgical margin. For the last-mentioned purpose, the epoxy
resin-embedded samples are prepared. Then, before electron
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microscopy studies are done toluidine blue-stained semi-thin
sections are examined. Using this technique, the pathologist
may evaluate more details including nuclear polymorphism,
cells in mitosis, as well the cellular characteristic (size, shapes,
size of nuclei, number of nucleoli per nucleus, presence of
polykaryocytes, typical cytoplasmic ultrastructural character-
istic for squamous epithelium). This technique allows also to
find more precisely suspected changes, as dysplastic or neo-
plastic cell “traveling” through normal tissue. Besides this,
immunohistochemistry and molecular analysis could bring
new information. It has to be underlined that genetic and
epigenetic changes are also detected in histopathologically
clean resection fields. It could cause local relapse in mucosa
primarily free of cancer cells. This has been explained by the
Slaughter’s model of “field cancerization” [12]. In turn, the
Califano model is based on the increased number of genetic
alterations in the field, with a division into early and late ones
[13]. Finally, there is the “patch-field” model proposed by
Braakhuis [14]. All these theories assume that the whole
mucosa is predisposed to carcinogenesis due to exposure to
exogenous genotoxins [15, 16].
Among the molecular alterations found in the early
stage of carcinogenesis are epigenetic changes. Silencing
of tumor suppressor genes associated with promoter
hypermethylation is a common feature in human cancers
and serves as a mechanism for the loss of their function.
[17–19]. The hypermethylation status of different genes
was stated to be important for prognosis in cancer pa-
tients. Methylation analyses are performed frequently
using tumor tissue, but some results showed that the
estimation of DNA methylation changes in the resection
margin has an even greater prognostic value [20].
The epigenetic alterations of CDKN2A (p16; located at
9p21), CDH1 (16q22.1), FHIT (3p14.2), RAR-β (3p24.2),
and ATM (11q22.3) have been found to be related to clinical
prognosis in cancer of the head and neck [18]. The analysis of
methylation of CDKN2A gene has been suggested to be a
useful method in the molecular diagnostics of the resection
field [21]. The hypermethylation of CDH1 gene was consid-
ered to be a bad prognostic factor in tongue cancer [22] and
ATM gene hypermethylation was connected with poorer prog-
nosis in head and neck cancers [23]. Methylated RAR-β gene
is completely suppressed in immortal dysplasia and oral car-
cinoma [24]. However, the results are still inconsistent; thus,
the search for epigenetic markers useful as prognostic factors
remains still an open question.
The aim of this study was to establish the morphological
characteristics of various parts of the tumor including com-
parisons between the central, peripheral part and the surgical
margin of the cancer of the oral cavity and oropharynx. We
also assessed the methylation status of five genes (CDKN2A,
CDH1, ATM, FHIT, and RAR-β) in the same samples. In the
following study, the correlations between morphological data,




Patients with oral and oropharyngeal cancer who had been
primarily treated surgically in the Department of
Otolaryngology and Clinical Oncology, University of Medical
Sciences in Poznań, Poland, between July 2009 and April 2012
were enrolled to the prospective study. The study group
consisted of 53 patients, 4 women and 49 men, aged 24–82.
The clinical data including sex, age, stage of the tumor, histo-
logical grading, risk factors, and localization of the tumor are
Table 1 The clinical characterization of the study group








Smoking and alcohol 13
















Tonsils (no infiltration of the base of the tongue) 13
Tongue (2/3 anterior, no infiltration of the floor of the mouth) 16
Tongue and floor of the mouth 11
Palate 3
Lips 1
Base on the tongue and tonsils 8
Cheek 1
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listed in Table 1. The tissue samples were taken from the central
(A) and peripheral part of the tumor (B) and from the surgical
margin (C). All samples underwent routine histopathological
examination (HE-stained specimens) and ultrastructural assess-
ment using toluidine blue staining in a light microscope and in
transmission electron microscopy (EM). The resection margin
was considered clean in histopathological examination, if the
distance from the invasive cancer to the margin was more than
5 mm—according to the UK Royal College of Pathologists.
DNAmethylation status for the chosen genes was established in
the same samples (A, B, and C).
Ultrastructural assessment
Tissue samples were pre-fixed in Karnovsky solution (glutar-
aldehyde 2 % and paraformaldehyde 3.4 % in 0.1 M
cacodylate buffer pH 7.4) overnight (1 h at room temperature
and cooled down to 4 °C). After pre-fixation, samples were
washed several times in 0.1 M phosphate buffer and post-
fixed in 1 % OsO4 in 0.1 M phosphate buffer with
K4Fe(CN)6·3H2O; 0.16 % for 3 h at +4 °C. After post-
fixation, dehydration in gradually increasing concentrations
of ethanol and then acetone was carried out. Embedding in
Epon 812 and polymerization were the next steps of the
procedure. Semi-thin sections were cut from all blocks,
stained with toluidine blue of basic pH, and checked with
the use of an Olympus BX 41. After selection of the proper
slide area ultrathin sections were cut and doubly stained with
uranium acetate and lead citrate for EM. Selection of ultrathin
section areas and micrographs was done by JEM 1011.
Since the aims of the study also included a careful check of
the margins of tumors and their periphery (oncologic sterility),
the control performed on the base of semi-thin sections was
very accurate. In case of any doubts concerning presence of
single tumor cells in surrounding tissue, EM checks were
done.
In this series, we compared groups with a clean resection
margin in HE-stained specimens and a positive margin in
morphological assessment, versus a group with a clean resec-
tion margin in both examinations with survival, TNM status,
G stage, and pN.
DNA extraction and gene methylation analysis
DNA was isolated from all samples according to standard
procedures (proteinase K digestion, phenol/chloroform ex-
traction, and ethanol precipitation). For DNA methylation
analysis, samples with more than 80 % of cancer cells in the
field were enrolled. The methylation status of RAR-β, CDH1,
FHIT, CDKN2A, and ATM was assessed using the
methylation-specific polymerase chain reaction (MSP).
DNAwas converted in the presence of sodium bisulfite using
the EZ DNA Methylation Kit from ZymoResearch (Orange,
CA, USA). TrueStart Hot Start Taq DNA Polymerase from
Fermentas (Burlington, Canada) was used for the amplifica-
tion of RAR-β and ATM, whereas FastStart Taq DNA
Polymerase (Roche Diagnostics, Germany) was used for the
amplification of CDH1, FHIT, and CDKN2A. The primers
and reaction conditions for MSP were as previously reported
in other studies [25–29]. All the primers were obtained from
Fig. 1 The chart is showing differences between two groups: without
neck metastases (pN0) and clean margin, and with neck metastases (pN1)
and positive margin in HE staining. The first one presents longer survival
in the Kaplan–Meier test
Fig. 2 The picture shows non-homogenous structure of the tumor
Fig. 3 This figure shows horny pearl in G1 texture; other cells are
modestly monomorphic in G1-2 carcinoma
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Oligo.pl (Warsaw, Poland). DNA extracted from the lympho-
cytes of healthy blood donors was used as a negative control,
and completely methylated human DNA (New England
Biolabs, Ipswich, MA, USA) was used as a positive control
in the MSP reactions. Amplification products were separated
on 2.5 % agarose gels and visualized in UV light after
ethidium bromide staining.
First, we compared the results obtained for groups A, B,
and C: samples with methylation vs those without it in relation
to TNM, pN, G stage, and survival. Then, groups A and B
were coupled (tumor zone) and these results were correlated
with clinicopathological data.
Statistical analysis
The correlation between clinicopathological features and re-
sults of morphological examination, as well as gene methyl-
ation, was assessed using Chi-square, Mann–Whitney, and
Kaplan–Meier tests (p<0.05). The Statistica program was
used for analysis.
Results
In the study group, the T2 stage of the tumor, N0 nodal involve-
ment, and G2 malignancy grading prevailed. Of the 53 patients,
12 had a positive surgical margin in histopathological examina-
tion. In the series with a clean resection margin, we did not find
histopathologically confirmed node metastases (pN) and the
result was statistically significant (p=0.0393). The second very
important point was the finding that the group with pN0 and
cleanmargin in HE staining, but having cancer cells in toluidine
blue staining, present longer survival in the Kaplan–Meier test
(Fig. 1).
None of the tumors collected for research had a homoge-
neous texture (Fig. 2). In all cancers, fields of differentiated
cells maturating to fully keratinized—or in the form of
keratinizing—horny pearls (Fig. 3), or small horny plates
lying on the free surface of the tumor occurred. Apart from
maturating cells, others which had cytoplasmic features typi-
cal for spinous cells, i.e., cytokeratin bunches and irregular
cytoplasmic bridges with irregular desmosomes or other
forms of intercellular junctions, were found. Cells differed in
size and shape of nuclei and cytoplasm (Fig. 4). Nuclear
polymorphism was distinct and considerable, especially in
the invasive front of the tumor. The ultrastructural character-
istics of nuclei were very different for these cells compared to
the nuclei of maturating cells. They were large, with an
irregular contour, often with deep invagination of the nuclear
envelope into the nucleoplasm (Fig. 5). Many nuclei had
Fig. 5 The micrograph presents differences between the nuclei of tumor
cells. One is much larger, with a deeply invaginated nuclear membrane,
enlarged active nucleolus, a field of interchromatin granules, and small
groups of heterochromatin located in the vicinity of the nuclear
membrane
Fig. 6 One of the tumor cells forms chromosomes and removes the
nuclear membrane. Display of organelles is typical for the prophase.
Neighboring cells do not divide
Table 2 The number and percentage of patients with clean and positive
resection margin in two types of examinations
Margin U Margin HE 0 Margin HE 1 Total
0 20 (37.74 %) 4 (7.55 %) 24 (45.28 %)
1 21 (39.62 %) 8 (15.09 %) 29 (54.72 %)
Total 41 (77.36 %) 12 (22.64 %) 53 (100 %)
U ultrastructural, HE hematoxylin and eosin-stained, 0 clean, 1 involved
Fig. 4 Solid area of the G2-G3 stage of the tumor. Significant polymor-
phism of nuclei with numerous nucleoli dominates in the general picture
of this tumor. The area occupied by nuclei evidently prevail over the area
of cytoplasm
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large, active, and numerous nucleoli. Parts of the nuclei were
euchromatinized and had active nucleoli and very numerous
perichromatin granules, with different diameters and areas of
interchromatin granules. This is typical for cells which enter
into the cell cycle. In the whole collected material, cells
occurred in mitosis—and some of them were atypical or
endomitotic, what could be interpreted as a loss of proper cell
cycle control (Fig. 6). In some of the assessed tumors, disor-
ders of the late telophase were found as a partial loss of the
nuclear envelope. All of the studies carried out show that
cancer formed heterogenous cellular populations, with differ-
ences of texture classified as different histological gradings:
G1 or G2 or G3. Most commonly, the cells with lower G were
found in the invasive front of the tumor. There was a statisti-
cally significant correlation between nuclei polymorphism
and T stage (p<0.0001), N stage (p<0.046), and metastases
to the lymph nodes confirmed in histopathological examina-
tion—pN (p<0.004). The number of cells in irregular mitosis
correlated with T stage (p<0.004), and highly with pN
(p<0.009). In the examined group, there were differences
between the clean resection margin in HE-stained specimens
and those assessed using toluidine blue (Table 2). In the
specimens prepared for the assessment of the ultrastructure
of the tumor, even under a light microscope, it was possible to
find cancer cells between normal glands, skeletal muscle cells,
and connective tissue stroma (Fig. 7).
We also correlated the group with a clean resection margin in
HE-stained specimens but having cancer cells in ultrastructural
examination with clinicopathological features. This group did
not present a poor prognosis and did not correlate with TNM
status or G stage. Apart from ultrastructural analysis, the meth-
ylation status of selected tumor suppressors was also assessed.
The methylation was found most often for CDH1 and
CDKN2A genes in the A and B groups. However, there was
no statistically significant correlation between gene hyperme-
thylation and stage of the tumor, nodal involvement, and G
stage, except for a correlation between CDH1 in the B and N1
stage (p=0.031). For the next two genes, RAR β and FHIT,
hypermethylation was found less frequently and also did not
correlate with clinicopathological data. We did not detect meth-
ylation of ATM gene in any of the samples under analysis. Gene
methylation was also found in the clean resection margin, and
the percentage ranged between 1.8 and 26.4 (Tables 3 and 4).
Altogether, the molecular changes in the resection margin did
not correlate with TNM, malignancy grading, or survival.
Likewise, combining the results of groups A and B did not
provide any correlation between hypermethylation and clinico-
pathological data.
In the Kaplan–Meier test, there was no statistically signif-
icant correlation between gene methylation and survival, ex-
cept methylation of CDKN2A. The group with CDKN2A
hypermethylation presented longer survival (Fig. 8).
Discussion
Five-year survival rates in oral cancer are still unsatisfactory.
The epidemiological data show some differences between
Western and Eastern European countries, as well as the
USA. However, they never cross the 50 % threshold [1, 7]
that points at a deep need to find new prognostic factors.
Carcinogenesis is a multistep process [15, 16]. Cancer devel-
opment is the result of the accumulation of molecular alterations.
Epigenetic and genetic changes lead to the deregulation of cell
cycle through (epi)mutations of tumor suppressor genes and
proto-oncogenes. In some of the cells, mutated genes conform
with a proliferative activity and are responsible for the progres-
sion of cells to invasive carcinoma. Environmental carcinogens
can initiate this process in the area of epithelial cells. The same
Fig. 7 Comparison between HE-
(a) and toluidine blue- (b) stained
specimens of the same patient.
First one were classified as a clean
resection margin; however, in the
second one single cancer cells are
present
Table 3 The presence of gene hypermethylation in the central (A) and
peripheral parts (B) of the tumor, as well in the surgical margin (C)
A B C
CDH1 20/53 24/53 14/53
(37.7 %) (45.3 %) (26.4 %)
p16 14/53 18/53 10/53
(26.4 %) (33.9 %) (18.8 %)
RARbeta 4/53 0 3/53
(7.5 %) (5.6 %)
FHIT 1/53 1/53 1/53
(1.8 %) (1.8 %) (1.8 %)
ATM 0 0 0
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carcinogens have often a global effect on the whole oral epithe-
lium. This fact can be responsible for the multifocal progression
of mutated cells toward invasive carcinoma by the same oral
mucosa and thus can be represented by the morphological
heterogeneity of cancer texture in the analyzed material. Our
study shows that none of the examined tumors had the homog-
enous structure. This tissue texture characteristic was represented
in small, medium, and large tumors, and was not dependent on
tumor primary location. The observations gathered in our study
are in line with the ideas formulated by Braakhuis [14]. It can
also be thought that progression of certain tumor cells to the
invasive stage does not take place simultaneously [30].
The gold standard in the assessment of cancer tissue is
histological examination using HE-stained samples.
Evaluation of the same tissue using a transmission electron
microscope improves the accuracy of the morphological char-
acteristics of examined cells. In papers describing carcinomas of
oral mucosa, attention was paid to the ultrastructural character-
istics of the architecture of tumors, formation and quality of the
epithelial basement membrane, junctional complexes, including
hemidesmosomes, cytoplasmic structures and the size, and
structure and chromatin characteristics of nuclei and nucleoli.
In the assessment of our specimens, we used previously de-
scribed data of ultrastructural estimation [31–33]. In our study,
special attention was paid to the characteristics of cell nuclei.
Polymorphism of these structures includes differences in size,
nuclear envelope contour (regular, oval without deep invagina-
tion, to deep indentation into the chromatin to polykaryocytes,
with a lack of nuclear envelope on some small areas of nuclei),
and structure of chromatin (heterochromatin beneath the nuclear
envelope to highly euchromatic nuclei with prominent and also
multiple, nucleoli). Additionally, in some tumor areas, regular as
well as irregular mitotic figures were present. In our study
group, there were statistically significant correlations between
nuclei polymorphism of A and B with T stage (p<0.0001), N
stage (p<0.046), and metastases to the lymph nodes confirmed
in histopathological examination (pN p<0.004). At the same
time, the second examined parameter, i.e., the number of cells in
irregular mitosis for the same area, correlated with the T stage
(p<0.004) and highly with pN (p<0.009). These findings could
explain the dynamics of cancer biology and could also be very
useful as a prognostic factor in oral cancer.
We also analyzed ultrastructure of the resection margin
because data regarding the prognostic importance of HE-
stained specimens are not clear-cut. Some authors conclude
that it is a robust prognosticator, whereas others contradict
this thesis [34–39]. Going to the details, the first group
supports the thesis that the presence of single cell or groups
of cells in stroma surrounding the main tumor texture in the
resection margin is a separate, negative predicting factor. In
the present study, this situation did not correlate with worse
prognosis. This may be at least partly explained by the fact
that patients after surgery routinely undergo additional ther-
apy, i.e., irradiation and/or chemotherapy which may be
sufficient to eliminate cancer cells and prevent local relapse.
The ultrastructural characteristics of cell nuclei, including
their heterogeneity encouraged us to confront themorphologic
Table 4 The analysis of gene
methylation in clean and involve
resection margin in two types of
examinations: U—ultrastructural
and HE—hematoxylin and eosin-
stained, “−”—clean, “+”—in-
volved; A—central part of tumor,
B—peripheral part of tumor and
C—resection margin
ATM CDH1 CDKN2A FHIT RAR-β
HE+ 0 A:5 (9.43 %) A:3 (5.66 %) 0 A:1 (1.88 %)
B:5 (9.43 %) B:5 (9.43 %) B:0
C:3 (5.66 %) C:4 (7.54 %) C:0
HE− 0 A:13 (24.52 %) A:10 (18.86 %) A:1 (1.88 %) A:2 (3.77 %)
B:16 (30.18 %) B:12 (22.64 %) B:1 (1.88 %) B:0
C:9 (16.98 %) C:6 (11.32 %) C:1 (1.88 %) C:2 (3.77 %)
U+ 0 A:15 (28.30 %) A:5 (9.43 %) A:1 (1.88 %) A:3 (5.66 %)
B:15 (28.30 %) B:7 (13.20 %) B:1 (1.88 %) B:0
C:10 (18.86 %) C:6 (11.32 %) C:1 (1.88 %) C:1 (1.88 %)
U− 0 A:5 (9.43 %) A:7 (13.20 %) 0 A:1 (1.88 %)
B:7 (13.20 %) B:9 (16.98 %) B: 0
C:3 (5.66 %) C:3 (5.66 %) C:1 (1.88 %)
Fig. 8 The chart shows that the group with p16 methylation (p16-M)
presents better survival than the group without hypermethylation (p16-U)
in the Kaplan–Meier test
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data with epigenetic profile. Solid tumors, like many other
human diseases, show aberrant epigenetic alterations [19,
40–42]. Methylation of CpG islands associated with tumor
suppressor genes is found to be crucial in the multistep mech-
anism of carcinogenesis. In our study, gene hypermethylation
was detected most commonly in CDH1 and CDKN2A genes
in central and peripheral parts of the tumor. These alterations
prevailed in the peripheral part of the tumor, what may be
associatedwith the presence ofmore rapidly proliferating cells
that are more susceptible to molecular changes. However,
only one statistically significant correlation was established
between CDH1 in the B zone and N stage. Data regarding the
hypermethylation process and its influence on clinicopatho-
logical features and prognosis are still unclear. Ha and
Califano [18] noticed that methylation of CDKN2A ranged
from 0 to 85 % in oral cancer. Nagata et al. found that
methylation of four statistically selected genes including E-
cadherin and RAR-β allows to detect oral cancer with 100 %
sensitivity and 87.5 % specificity [43].
In our study, CDKN2A hypermethylation did not correlate
with clinicopathological data, except survival, which was
observed in the Kaplan–Meier curve. Hence, our observa-
tions for only this one parameter are in agreement with other
authors, claiming the usefulness of the determination of the
methylation status of CDKN2A as prognosis marker
[44–47]. Dong et al. [44] found a statistically significant
correlation between methylation of CDKN2A and nodal
involvement and survival in buccal carcinoma, however,
without association with gender, age, T stage, and G stage.
In this study, the overall survival was poorer for the group
with hypermethylation in the Kaplan–Meier test, but in
multivariable analysis using the Cox regression model meth-
ylation was not statistically correlated with survival. In a
multicentre study covering 353 cases of head and neck
cancer, Roh et al. found that CDKN2A methylation correlat-
ed with a decreased survival [45]. However, in tumors with
disruptive TP53 mutation, methylation of CDKN2A was
protective. In our study, TP53 mutations were not tested.
Veganzones-de-Castro et al. working on colorectal cancer
made the same observation as we did [48]. They found that
patients with poorly differentiated tumors having CDKN2A
promoter methylated presented longer free survival than
those without CDKN2A methylation. We cannot rule out
that only one allele was methylated and the other one still
remained and performed its function.
The methylation of RAR-β and FHIT was found less
frequently in the central and peripheral parts of the tumor.
In our study, methylation of these two genes did not corre-
late with age, stage of the tumor, malignancy grading, or
survival. However, the methylation in tumor zone was more
prevalent than in the resection margin. Tanaka et al. [49]
found that methylation of the 5′ CpG island is an important
mechanism for the inactivation of the FHIT gene in
esophageal carcinoma. Hypermethylation of FHIT was rela-
tively often found in oral cancer (27 %) [18] and in laryngeal
carcinoma (26 %) [50]. However, it did not correlate with
clinicopathological data and survival. RAR-β is completely
suppressed in immortal dysplasia and oral carcinoma [24].
Hypermethylation was often found in oral cancer (47–100 %)
[18], and relatively often in the laryngeal cell lines (64.7 %)
[51]. Paluszczak et al. found the methylation of this gene in
59 % of laryngeal carcinoma cases, but it did not correlate with
prognosis [50]. We found the same statistical results in our
study. In our group of patients, we did not find aberrant meth-
ylation of ATM. Hypermethylation of this gene in HNSCC was
described as connected with poorer prognosis [23, 52] but we
did not confirm these observations.
The molecular assessment of the surgical margin was an
important part of our research. In our study, we did not find
statistically significant correlation between methylation of the
resection margin and prognosis. Methylation of CDKN2A in
the surgical margin was found as a prognostic factor for
tongue cancer by Sinha et al. [20]. Other authors, however,
found molecular changes in the resection margin, but without
correlation with survival [21, 53]. Some authors propose
criteria which determine the reliability of a molecular marker
in the resection field [54, 55]. After the precise analysis
Bradley et al. [54] concluded that the TP53 mutations fulfil
the proposed criteria. Finally, we should keep in mind that
cancer recurrence could have many reasons, which was pre-
cisely described by Braakhuis et al. [56].
In conclusion, we would like to stress that ultrastructural
assessment in our patient group brought important informa-
tion about cancer biology. Parameters like nuclei polymor-
phism and number of cells in irregular mitosis are strong
prognosticators of patient survival. The epigenetic changes
found in the tumor area did not correlate with clinicopatho-
logical features except CDKN2A methylation, which was
correlated with better prognosis. The molecular assessment
of the resection margin did not bring new prognostic infor-
mation. However, a longer observation time and a larger
number of patients are required to draw final conclusions.
Overall, we report frequent changes in tissue ultrastructure
and gene hypermethylation of CDKN2A and CDH1 in oral
cancer. The inclusion to our study of the estimation of other
molecular parameters may result in the discovery of novel,
prognostic markers of this disease.
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